Clinical Trial Update: Likely Use of PrEP for African American YMSM

View source ↗

Summary

This completed clinical trial provides an update on the likely use of PrEP for HIV prevention among African American young men who have sex with men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Duke University | Conditions: HIV | Status: COMPLETED